Pediatric Neuroblastoma Treatment Global Market Report 2025

Global Pediatric Neuroblastoma Treatment Market Report 2024

Pediatric Neuroblastoma Treatment Global Market Report 2025 – By Treatment Type (Immunotherapy, Chemotherapy, Radiation Therapy, Other Treatment Types), By Risk Group (Low Risk, Intermediate Risk, High Risk), By End User (Hospitals, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Pediatric Neuroblastoma Treatment Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Pediatric Neuroblastoma Treatment Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Pediatric Neuroblastoma Treatment Global Market Report 2025

Proud Members Of

Pediatric Neuroblastoma Treatment Market Definition

Pediatric neuroblastoma treatment refers to a kind of treatment for cancer or a tumor that affects the nervous system in children. Neuroblastoma is typically treated with a combination of surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy.

The main types of pediatric neuroblastoma treatments are immunotherapy, chemotherapy, radiation therapy, and others. Immunotherapy is a form of medical treatment that uses the immune system's power to fight disease. It is used to treat several risk groups, such as low risk, intermediate risk, and high risk, and is used by various end users including hospitals, specialty clinics, and others.

Pediatric Neuroblastoma Treatment Market Segmentation

The pediatric neuroblastoma treatment market covered in this report is segmented –

1) By Treatment Type: Immunotherapy, Chemotherapy, Radiation Therapy, Other Treatment Types

2) By Risk Group: Low Risk, Intermediate Risk, High Risk

3) By End User: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Immunotherapy: Monoclonal Antibodies, Immune Checkpoint Inhibitors, CAR T-Cell Therapy

2) By Chemotherapy: Alkylating Agents, Antimetabolites, Topoisomerase Inhibitors

3) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Radioisotope Therapy

4) By Other Treatment Types: Surgery, Stem Cell Transplantation, Targeted Therapy

Pediatric Neuroblastoma Treatment Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

Pediatric Neuroblastoma Treatment Market Size 2025 And Growth Rate

The pediatric neuroblastoma treatment market size has grown strongly in recent years. It will grow from $1.85 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to advancements in treatment modalities, increased awareness and early diagnosis, research and development initiatives, collaborative efforts, improved survival rates.

Pediatric Neuroblastoma Treatment Market Growth Forecast

The pediatric neuroblastoma treatment market size is expected to see strong growth in the next few years. It will grow to $2.87 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to emerging therapies, personalized medicine, global health initiatives, expanded access to treatment, patient advocacy and support. Major trends in the forecast period include collaborative research initiatives, gene therapy breakthroughs, novel drug development, early diagnosis and screening, patient advocacy and support.

Book your 30 minutes free consultation with our research experts

Pediatric Neuroblastoma Treatment Market Driver: Surging Pediatric Neuroblastoma Cases Propel Advancements In Treatment Market A Focus On Research, Innovation, And Early Detection

The rising number of new cases of pediatric neuroblastoma is expected to propel the growth of the pediatric neuroblastoma treatment market going forward. The rising prevalence of neuroblastoma is increasing the demand for pediatric neuroblastoma treatment alternatives. As a result, pharmaceutical corporations and other stakeholders have boosted their investment in research and development, promoting innovation in the industry. Furthermore, the availability of new diagnostic technology and screening procedures has resulted in earlier neuroblastoma discovery, allowing for earlier treatments and better outcomes. For instance, in March 2023, according to an article published by the American Society of Clinical Oncology (ASCO), a US-based organization for oncology professionals and physicians, neuroblastoma affects approximately 700 to 800 youngsters in the United States each year. In the United States, neuroblastoma accounts for 6% of all childhood malignancies. Neuroblastoma affects around 90% of children under the age of five. Therefore, the rising number of new cases of pediatric neuroblastoma is driving the growth of the pediatric neuroblastoma treatment market.

Pediatric Neuroblastoma Treatment Market Driver: Rising Healthcare Infrastructure Investments Fueling Growth In The Pediatric Neuroblastoma Treatment Market

The increasing improvement in healthcare infrastructure is expected to propel the growth of the pediatric neuroblastoma treatment market. Healthcare infrastructure refers to the organizational and physical structures, buildings, processes, and resources that collectively enable the delivery of healthcare services within a community, region, or country. The healthcare infrastructure serves as the basis for pediatric neuroblastoma patients' diagnosis, treatment, and support. Its many components work together to provide comprehensive treatment, stimulate research and innovation, and improve the general health of children with neuroblastoma. For instance, in March 2022, the Department of Health and Aged Care, an Australia-based government agency in charge of funding, promoting, regulating, and doing health research, announced that the newly elected Coalition Government is investing a record $132 billion in 2022–23 for healthcare infrastructure, increasing to $140 billion in 2025–26, for a total commitment of $537 billion over the following four years. Therefore, the increasing improvement in healthcare infrastructure is driving the pediatric neuroblastoma treatment market.

Global Pediatric Neuroblastoma Treatment Market Major Players

Major companies operating in the pediatric neuroblastoma treatment market include United Therapeutics Corporation, APEIRON Biologics AG, Baxter International Inc., Cell Ectar Biosciences Inc., Pfizer Inc., MacroGenics Inc., Bayer AG, Provectus Biopharmaceuticals Inc., Sartorius AG, Y-mAbs Therapeutics Inc., Amgen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Clarity Pharmaceuticals, CureSearch for Children's Cancer, Novartis AG, Johnson & Johnson Services Inc., AbbVie Inc., Merck & Co. Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company Limited, Eisai Co. Ltd.

Global Pediatric Neuroblastoma Treatment Market Trend: Antibody Technologies in Pediatric Neuroblastoma Treatment

Major companies operating in the pediatric neuroblastoma treatment market are developing technologies such as antibody technologies to enhance targeted therapy efficacy and improve patient outcomes. Antibody technologies encompass various methods and tools for developing, producing, and utilizing antibodies for diagnostics, therapeutics, and research applications. For instance, in August 2023, Renaissance Pharma Ltd, a UK-based clinical-stage biopharmaceutical company, launched Hu14.18K322A. Hu14.18K322A targets GD2, a disialoganglioside present on the surface of neuroblastoma cells. By binding to these cells, it recruits immune effector cells to attack and kill the tumor cells, potentially improving treatment outcomes for patients with high-risk neuroblastoma.

Global Pediatric Neuroblastoma Treatment Market Trend: Strategic Partnerships In Pediatric Neuroblastoma Treatment Market Drive Collaborative Breakthroughs

Major companies operating in the pediatric neuroblastoma treatment market are adopting a strategic partnership approach aiming to produce novel drug for high-risk neuroblastoma. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in August 2023, Renaissance Pharma Ltd., a UK-based biopharmaceutical company, announced a license agreement with the St. Jude Children’s Research Hospital for Hu14.18, a humanized antibody that the institution is developing for the medical management of newly identified high-risk neuroblastoma. Hu14.18 is a humanized anti-GD2 mAb. A unique Phase II study adding Hu14.18 to both induction and post-consolidation treatment exhibited excellent patient outcomes with an OS of 86.0% and EFS of 73.7%4. The licensing deal provides Renaissance Pharma with exclusive development, production, and commercialization rights in the United States, Canada, Europe, China, Japan, and Turkey. The St. Jude Children’s Research Hospital is a US-based research hospital.

Pediatric Neuroblastoma Treatment Market Merger And Acquisition: Recordati S.P.A. Expands Pharmaceutical Portfolio With Acquisition Of Eusa Pharma (UK) Ltd., Enhancing Focus On Pediatric Neuroblastoma Treatment

In March 2022, Recordati S.p.A., an Italy-based pharmaceutical group, acquired EUSA Pharma (UK) Ltd. for $824.28 million. The acquisition is expected to offer Recordati a broader portfolio of pharmaceuticals for rare diseases. EUSA Pharma (UK) Ltd. is a UK-based specialty pharmaceutical company that deals in pediatric neuroblastoma treatment.

Regional Analysis For The Global Pediatric Neuroblastoma Treatment Market

North America was the largest region in the pediatric neuroblastoma treatment market in 2024. The regions covered in the pediatric neuroblastoma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pediatric neuroblastoma treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pediatric Neuroblastoma Treatment Market?

The pediatric neuroblastoma treatment market consists of revenues earned by entities by providing pediatric neuroblastoma treatment services such as stem cell therapy, supportive care and blood transfusions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric neuroblastoma treatment market also includes sales of pain management medications, chemotherapy drugs and immunotherapy agents which are used in providing pediatric neuroblastoma treatment services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pediatric Neuroblastoma Treatment Industry?

The pediatric neuroblastoma treatment market research report is one of a series of new reports from The Business Research Company that provides pediatric neuroblastoma treatment market statistics, including pediatric neuroblastoma treatment industry global market size, regional shares, competitors with a pediatric neuroblastoma treatment market share, detailed pediatric neuroblastoma treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric neuroblastoma treatment industry. This pediatric neuroblastoma treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pediatric Neuroblastoma Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.03 billion
Revenue Forecast In 2034	$2.87 billion
Growth Rate	CAGR of 9.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Treatment Type: Immunotherapy, Chemotherapy, Radiation Therapy, Other Treatment Types 2) By Risk Group: Low Risk, Intermediate Risk, High Risk 3) By End User: Hospitals, Specialty Clinics, Other End Users Subsegments: 1) By Immunotherapy: Monoclonal Antibodies, Immune Checkpoint Inhibitors, CAR T-Cell Therapy 2) By Chemotherapy: Alkylating Agents, Antimetabolites, Topoisomerase Inhibitors 3) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Radioisotope Therapy 4) By Other Treatment Types: Surgery, Stem Cell Transplantation, Targeted Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	United Therapeutics Corporation, APEIRON Biologics AG, Baxter International Inc., Cell Ectar Biosciences Inc., Pfizer Inc., MacroGenics Inc., Bayer AG, Provectus Biopharmaceuticals Inc., Sartorius AG, Y-mAbs Therapeutics Inc., Amgen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Clarity Pharmaceuticals, CureSearch for Children's Cancer, Novartis AG, Johnson & Johnson Services Inc., AbbVie Inc., Merck & Co. Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company Limited, Eisai Co. Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Pediatric Neuroblastoma Treatment Market Characteristics

3. Pediatric Neuroblastoma Treatment Market Trends And Strategies

4. Pediatric Neuroblastoma Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pediatric Neuroblastoma Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Pediatric Neuroblastoma Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pediatric Neuroblastoma Treatment Market Growth Rate Analysis

5.4. Global Pediatric Neuroblastoma Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pediatric Neuroblastoma Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pediatric Neuroblastoma Treatment Total Addressable Market (TAM)

6. Pediatric Neuroblastoma Treatment Market Segmentation

6.1. Global Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunotherapy

Chemotherapy

Radiation Therapy

Other Treatment Types

6.2. Global Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Low Risk

Intermediate Risk

High Risk

6.3. Global Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Other End Users

6.4. Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Immune Checkpoint Inhibitors

CAR T-Cell Therapy

6.5. Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alkylating Agents

Antimetabolites

Topoisomerase Inhibitors

6.6. Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

External Beam Radiation Therapy (EBRT)

Radioisotope Therapy

6.7. Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgery

Stem Cell Transplantation

Targeted Therapy

7. Pediatric Neuroblastoma Treatment Market Regional And Country Analysis

7.1. Global Pediatric Neuroblastoma Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pediatric Neuroblastoma Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pediatric Neuroblastoma Treatment Market

8.1. Asia-Pacific Pediatric Neuroblastoma Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pediatric Neuroblastoma Treatment Market

9.1. China Pediatric Neuroblastoma Treatment Market Overview

9.2. China Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pediatric Neuroblastoma Treatment Market

10.1. India Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pediatric Neuroblastoma Treatment Market

11.1. Japan Pediatric Neuroblastoma Treatment Market Overview

11.2. Japan Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pediatric Neuroblastoma Treatment Market

12.1. Australia Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pediatric Neuroblastoma Treatment Market

13.1. Indonesia Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pediatric Neuroblastoma Treatment Market

14.1. South Korea Pediatric Neuroblastoma Treatment Market Overview

14.2. South Korea Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pediatric Neuroblastoma Treatment Market

15.1. Western Europe Pediatric Neuroblastoma Treatment Market Overview

15.2. Western Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pediatric Neuroblastoma Treatment Market

16.1. UK Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pediatric Neuroblastoma Treatment Market

17.1. Germany Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pediatric Neuroblastoma Treatment Market

18.1. France Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pediatric Neuroblastoma Treatment Market

19.1. Italy Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pediatric Neuroblastoma Treatment Market

20.1. Spain Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pediatric Neuroblastoma Treatment Market

21.1. Eastern Europe Pediatric Neuroblastoma Treatment Market Overview

21.2. Eastern Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pediatric Neuroblastoma Treatment Market

22.1. Russia Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pediatric Neuroblastoma Treatment Market

23.1. North America Pediatric Neuroblastoma Treatment Market Overview

23.2. North America Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pediatric Neuroblastoma Treatment Market

24.1. USA Pediatric Neuroblastoma Treatment Market Overview

24.2. USA Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pediatric Neuroblastoma Treatment Market

25.1. Canada Pediatric Neuroblastoma Treatment Market Overview

25.2. Canada Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pediatric Neuroblastoma Treatment Market

26.1. South America Pediatric Neuroblastoma Treatment Market Overview

26.2. South America Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pediatric Neuroblastoma Treatment Market

27.1. Brazil Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pediatric Neuroblastoma Treatment Market

28.1. Middle East Pediatric Neuroblastoma Treatment Market Overview

28.2. Middle East Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pediatric Neuroblastoma Treatment Market

29.1. Africa Pediatric Neuroblastoma Treatment Market Overview

29.2. Africa Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pediatric Neuroblastoma Treatment Market Competitive Landscape And Company Profiles

30.1. Pediatric Neuroblastoma Treatment Market Competitive Landscape

30.2. Pediatric Neuroblastoma Treatment Market Company Profiles

30.2.1. United Therapeutics Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.2. APEIRON Biologics AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Cell Ectar Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pediatric Neuroblastoma Treatment Market Other Major And Innovative Companies

31.1. MacroGenics Inc.

31.2. Bayer AG

31.3. Provectus Biopharmaceuticals Inc.

31.4. Sartorius AG

31.5. Y-mAbs Therapeutics Inc.

31.6. Amgen Inc.

31.7. Eli Lilly and Company

31.8. F. Hoffmann-La Roche AG

31.9. Clarity Pharmaceuticals

31.10. CureSearch for Children's Cancer

31.11. Novartis AG

31.12. Johnson & Johnson Services Inc.

31.13. AbbVie Inc.

31.14. Merck & Co. Inc.

31.15. Bristol-Myers Squibb Company

32. Global Pediatric Neuroblastoma Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pediatric Neuroblastoma Treatment Market

34. Recent Developments In The Pediatric Neuroblastoma Treatment Market

35. Pediatric Neuroblastoma Treatment Market High Potential Countries, Segments and Strategies

35.1 Pediatric Neuroblastoma Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Pediatric Neuroblastoma Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Pediatric Neuroblastoma Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Pediatric Neuroblastoma Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Pediatric Neuroblastoma Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: United Therapeutics Corporation Financial Performance

Table 79: APEIRON Biologics AG Financial Performance

Table 80: Baxter International Inc. Financial Performance

Table 81: Cell Ectar Biosciences Inc. Financial Performance

Table 82: Pfizer Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Pediatric Neuroblastoma Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Pediatric Neuroblastoma Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Pediatric Neuroblastoma Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By Risk Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Pediatric Neuroblastoma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: United Therapeutics Corporation Financial Performance

Figure 79: APEIRON Biologics AG Financial Performance

Figure 80: Baxter International Inc. Financial Performance

Figure 81: Cell Ectar Biosciences Inc. Financial Performance

Figure 82: Pfizer Inc. Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Gastrointestinal Bleeding Treatment Devices Global Market Report 2025 – By Product (Endoscopic Thermal Devices, Other Products), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End User (Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gastrointestinal Devices Global Market Report 2025 – By Product Type (GI Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, Endoscopic Mucosal Resection (EMR), Hemostasis Devices, Other Product Types), By Sales Channel (Online Retailing, Medical Stores & Brand Outlet), By End Users (Hospitals, Clinics & Dialysis Centers, Ambulatory Surgical Center) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Medical Equipment Maintenance Global Market Report 2025 – By Service Type (Preventive Maintenance, Corrective Maintenance, Operational Maintenance), By Device (Imaging Equipment, Endoscopic Devices, Surgical Instruments, Electro-medical Equipment), By Technology (Multi-Vendor OEMs, Single-Vendor OEMs, Independent Service Organization, In-House Maintenance), By End User (Hospital, Diagnostic Imaging Centers, Dialysis Centers, Ambulatory Surgical Centers, Dental Clinics And Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Medication Adherence Global Market Report 2025 – By Type (Hardware Centric, Software Centric), By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Respiratory, Gastrointestinal, Rheumatology, Other Medications), By Application (Hospital, Retail Pharmacies, Long-Term Care Facilities, Mail-Order Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Dialysis Devices And Equipment Global Market Report 2025 – By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By Application (Serum And Blood Treatment, Virus Purification, Drug Binding Studies), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biosimilar Therapeutic Peptides Global Market Report 2025 – By Type (Innovative, Generic), By Route Of Administration (Parenteral Route, Transdermal Route, Other Route Of Administrations), By Application (Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Endoscopy Devices And Equipment Global Market Report 2025 – By Product (Endoscope, Endoscopy Operative Devices, Endoscopy Visualization Systems), By Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuroendoscopy, Gastrointestinal Endoscopy, Obstetrics/Gynecology Endoscopy, ENT Endoscopy, Other Applications), By End-User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hemodialysis And Peritoneal Dialysis Global Market Report 2025 – By Type (Hemodialysis, Short-Term Catheter, Chronic Catheter, Graft, Fistula, Peritoneal Dialysis), By Modality (Conventional, Daily (Day Time, Night Time)), By End User (Hospitals, Clinics, And Dialysis Centers, Home Dialysis) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the pediatric neuroblastoma treatment market?

How will the pediatric neuroblastoma treatment market drivers and restraints affect the pediatric neuroblastoma treatment market dynamics? What forces will shape the pediatric neuroblastoma treatment industry going forward?

The pediatric neuroblastoma treatment market major growth driver - Pediatric neuroblastoma treatment refers to a kind of treatment for cancer or a tumor that affects the nervous system in children. Neuroblastoma is typically treated with a combination of surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy.. For further insights on the pediatric neuroblastoma treatment market, request a sample here

What is the forecast market size or the forecast market value of the pediatric neuroblastoma treatment market?

The pediatric neuroblastoma treatment market size has grown strongly in recent years. It will grow from $1.85 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to advancements in treatment modalities, increased awareness and early diagnosis, research and development initiatives, collaborative efforts, improved survival rates. The pediatric neuroblastoma treatment market size is expected to see strong growth in the next few years. It will grow to $2.87 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to emerging therapies, personalized medicine, global health initiatives, expanded access to treatment, patient advocacy and support. Major trends in the forecast period include collaborative research initiatives, gene therapy breakthroughs, novel drug development, early diagnosis and screening, patient advocacy and support. For further insights on the pediatric neuroblastoma treatment market, request a sample here

How is the pediatric neuroblastoma treatment market segmented?

The pediatric neuroblastoma treatment market is segmented
1) By Treatment Type: Immunotherapy, Chemotherapy, Radiation Therapy, Other Treatment Types
2) By Risk Group: Low Risk, Intermediate Risk, High Risk
3) By End User: Hospitals, Specialty Clinics, Other End Users Subsegments:
1) By Immunotherapy: Monoclonal Antibodies, Immune Checkpoint Inhibitors, CAR T-Cell Therapy
2) By Chemotherapy: Alkylating Agents, Antimetabolites, Topoisomerase Inhibitors
3) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Radioisotope Therapy
4) By Other Treatment Types: Surgery, Stem Cell Transplantation, Targeted Therapy For further insights on the pediatric neuroblastoma treatment market, request a sample here

Which region has the largest share of the pediatric neuroblastoma treatment market? What are the other regions covered in the report?

North America was the largest region in the pediatric neuroblastoma treatment market in 2024. The regions covered in the pediatric neuroblastoma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the pediatric neuroblastoma treatment market, request a sample here.

Who are the major players in the pediatric neuroblastoma treatment market?

What are the key trends in the pediatric neuroblastoma treatment market?

Major trend in the pediatric neuroblastoma treatment market - Antibody Technologies in Pediatric Neuroblastoma Treatment. For further insights on the pediatric neuroblastoma treatment market, request a sample here.

What are the major opportunities in the pediatric neuroblastoma treatment market? What are the strategies for the pediatric neuroblastoma treatment market?

For detailed insights on the major opportunities and strategies in the pediatric neuroblastoma treatment market, request a sample here.

How does the pediatric neuroblastoma treatment market relate to the overall economy and other similar markets?

For detailed insights on pediatric neuroblastoma treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the pediatric neuroblastoma treatment industry?

For detailed insights on the mergers and acquisitions in the pediatric neuroblastoma treatment industry, request a sample here.

What are the key dynamics influencing the pediatric neuroblastoma treatment market growth? SWOT analysis of the pediatric neuroblastoma treatment market.

For detailed insights on the key dynamics influencing the pediatric neuroblastoma treatment market growth and SWOT analysis of the pediatric neuroblastoma treatment industry, request a sample here.